tiprankstipranks
Trending News
More News >
Olaplex Holdings (OLPX)
NASDAQ:OLPX
US Market

Olaplex Holdings (OLPX) AI Stock Analysis

Compare
247 Followers

Top Page

OLPX

Olaplex Holdings

(NASDAQ:OLPX)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
$1.50
▼(-9.09% Downside)
The score is held back primarily by the sharp profitability reset and slightly negative net income despite continued positive (but weakening) free cash flow. Technicals are supportive with the stock trading above major moving averages and positive MACD, while valuation remains unattractive due to a negative P/E. Earnings call commentary was constructive on product innovation and maintained guidance, but ongoing sales declines and channel weakness temper the outlook.
Positive Factors
Acquisition driving science-led innovation
Acquiring Purvala adds a science-driven R&D asset that can create proprietary, bio-inspired formulations. This materially strengthens Olaplex’s long-term product pipeline and differentiation, supporting sustainable premiumization, repeat purchases and higher margins over multiple years.
Very high gross margins
Sustained gross margins near 70% provide a durable profitability buffer, allowing the company to absorb higher marketing or R&D spend while protecting unit economics. This structural margin strength supports reinvestment in brand and product development over the medium term.
Positive free cash flow and lower leverage
Positive FCF alongside declining debt enhances financial flexibility, enabling continued investment in innovation, marketing, or opportunistic M&A without over-reliance on external financing. Improved leverage (debt-to-equity falling) reduces solvency risk and supports strategic optionality.
Negative Factors
Profitability compression
A sharp drop in operating profitability and a return to net loss signal weakened earnings power. If higher operating costs or weaker sales persist, ROE and internal funding capacity will be impaired, limiting long-term growth investments and reducing resilience to demand shocks.
Declining sales and channel weakness
Structural declines in key channels, notably specialty retail, and overall sales shrinkage versus a faster-growing prestige haircare market suggest deteriorating distribution and consumer traction. Persistent channel losses would pressure long-term top-line growth and market share recovery.
Concentrated ownership and takeover dynamics
Very high ownership concentration and an external takeover bid create governance and strategic uncertainty for minority stakeholders. Concentrated control can limit public-market liquidity and dictate strategic outcomes, potentially shortening the company’s independent long-term strategic path.

Olaplex Holdings (OLPX) vs. SPDR S&P 500 ETF (SPY)

Olaplex Holdings Business Overview & Revenue Model

Company DescriptionOlaplex Holdings, Inc. manufactures and sells hair care products. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company was founded in 2014 and is based in Santa Barbara, California.
How the Company Makes MoneyOlaplex generates revenue primarily through the sale of its hair care products, which are distributed through professional salons and retail channels. The company operates a dual revenue model: direct sales to professional hair salons and sales through retail partners, including e-commerce platforms. Key revenue streams include sales of its core products, particularly the Olaplex No. 1 through No. 8 line, which has gained significant traction in both the professional and consumer markets. Additionally, Olaplex collaborates with salons to provide training and support for stylists, enhancing the brand's presence and driving product adoption. The company also benefits from a strong brand reputation and customer loyalty, which contribute to repeat purchases and sustained sales growth.

Olaplex Holdings Key Performance Indicators (KPIs)

Any
Any
Net Sales by Geography
Net Sales by Geography
Chart Insights
Data provided by:The Fly

Olaplex Holdings Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 10, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mix of positive and negative aspects. While the company exceeded expectations and launched successful new products, challenges remain with declining net sales and market share lagging behind industry growth. Strategic investments show promise, but the macro environment and industry pressures add uncertainty.
Q3-2025 Updates
Positive Updates
Exceeded Expectations Despite Sales Decline
Net sales were $114.6 million, down 3.8% year-over-year, yet better than expectations. Adjusted EBITDA was $30.8 million, a margin of 26.9%, exceeding internal expectations.
Professional Channel Growth
Professional net sales grew 5.3% year-over-year to $44.5 million, driven by strong management of promotions and strategic initiatives.
Successful Product Launches
The launch of the Rich Hydration Mask and Weightless Nourishing Mask exceeded expectations with strong sell-in and sell-through, supported by a 360-degree marketing campaign.
Strong Adjusted Gross Profit Margin
Adjusted gross profit margin was 71.5%, up 70 basis points year-over-year.
Strategic Investments in Brand Demand and Innovation
Significant investments in brand demand and innovation led to early signs of success, including increased brand awareness and positive consumer response.
Purvala Bioscience Acquisition
The acquisition aims to develop transformative bio-inspired technologies, potentially creating the next generation of disruptive science-backed product innovation.
Negative Updates
Decline in Net Sales
Total net sales declined 3.8% year-over-year, with specialty retail sales down 13.5% and direct-to-consumer sales down 2.9%.
Market Share Lagging
Sell-out is lagging behind the prestige hair care market, which is growing mid-to-high single digits.
Uncertain Macro Environment
The macro environment remains uncertain, with consumer sentiment increasingly cautious heading into the holiday season.
Industry Destocking Pressure
Planned industry destocking is expected to pressure fourth-quarter results, particularly in the DTC channel.
Company Guidance
In the Olaplex Holdings, Inc. third quarter 2025 earnings call, the company reported net sales of $114.6 million, reflecting a 3.8% year-over-year decrease but surpassing internal expectations, partly due to earlier shipment timings. Adjusted EBITDA was $30.8 million, representing a margin of 26.9%. Professional channel sales increased by 5.3% year-over-year, driven by effective promotion management, while specialty retail sales declined by 13.5%, and direct-to-consumer sales fell by 2.9%. The company reiterated its annual guidance, expecting net sales to range from -3% to +2% year-over-year, an adjusted gross margin between 70.5% and 71.5%, and an adjusted EBITDA margin of 20% to 22%. Significant investments were made in brand demand, innovation, and execution, with notable success in the launch of two new hair masks, which exhibited strong sell-in and sell-through performance. Additionally, Olaplex announced the acquisition of Purvala Bioscience, underscoring its commitment to scientific innovation and potential future product development.

Olaplex Holdings Financial Statement Overview

Summary
Olaplex Holdings shows a mixed financial performance. Strong gross margins and improved leverage are positive, but profitability challenges and declining operational margins are concerning. Positive cash flow trends offer some optimism.
Income Statement
34
Negative
Olaplex Holdings has shown a mixed performance in its income statement. The TTM data indicates a slight revenue growth of 0.56%, but the company is currently experiencing a negative net profit margin of -0.30%, indicating a loss. The gross profit margin remains strong at 68.90%, suggesting efficient production processes. However, the declining EBIT and EBITDA margins over the years highlight challenges in operational efficiency and cost management.
Balance Sheet
63
Positive
The balance sheet shows a moderate financial position with a debt-to-equity ratio of 0.40 in the TTM, indicating a decrease in leverage compared to previous years. However, the return on equity is negative at -0.15%, reflecting the recent net loss. The equity ratio stands at 57.64%, suggesting a stable capital structure with a reasonable proportion of equity financing.
Cash Flow
55
Neutral
Cash flow analysis reveals a positive trajectory with a free cash flow growth rate of 5.75% in the TTM. The operating cash flow to net income ratio is 0.84, indicating that the company generates sufficient cash from operations relative to its net income. The free cash flow to net income ratio is nearly 1, suggesting efficient cash conversion from profits.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue418.58M422.67M458.30M704.27M598.37M282.25M
Gross Profit278.06M292.29M318.63M519.55M473.82M179.59M
EBITDA91.91M143.39M186.77M398.34M385.70M131.78M
Net Income-4.95M19.52M61.59M244.07M220.78M39.28M
Balance Sheet
Total Assets1.51B1.77B1.74B1.70B1.56B1.33B
Cash, Cash Equivalents and Short-Term Investments286.38M585.97M466.40M322.81M186.39M10.96M
Total Debt352.10M650.46M655.77M662.77M758.20M775.48M
Total Liabilities625.47M893.32M895.37M916.72M1.04B802.16M
Stockholders Equity888.75M874.40M844.97M780.96M524.30M530.67M
Cash Flow
Free Cash Flow72.42M138.18M173.92M254.67M198.26M128.95M
Operating Cash Flow75.65M143.07M177.53M255.32M200.03M128.97M
Investing Cash Flow-13.81M-4.89M-3.61M-2.68M-6.26M-1.38B
Financing Cash Flow-314.29M-18.61M-30.33M-116.22M-18.34M1.26B

Olaplex Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.65
Price Trends
50DMA
1.26
Positive
100DMA
1.29
Positive
200DMA
1.32
Positive
Market Momentum
MACD
0.11
Negative
RSI
65.11
Neutral
STOCH
65.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OLPX, the sentiment is Positive. The current price of 1.65 is above the 20-day moving average (MA) of 1.44, above the 50-day MA of 1.26, and above the 200-day MA of 1.32, indicating a bullish trend. The MACD of 0.11 indicates Negative momentum. The RSI at 65.11 is Neutral, neither overbought nor oversold. The STOCH value of 65.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OLPX.

Olaplex Holdings Risk Analysis

Olaplex Holdings disclosed 50 risk factors in its most recent earnings report. Olaplex Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Olaplex Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$29.45B25.4447.97%5.45%4.28%
76
Outperform
$1.54B8.3227.54%-0.42%31.64%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
$13.31B66.2259.58%9.80%-46.84%
57
Neutral
$1.09B-215.79-0.56%-3.47%-111.68%
57
Neutral
$6.08B43.051.98%-20.98%
53
Neutral
$4.71B7.084.16%-1.04%-20.88%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OLPX
Olaplex Holdings
1.64
0.06
3.80%
BBWI
Bath & Body Works
23.02
-12.50
-35.19%
SBH
Sally Beauty
15.72
4.57
40.99%
ULTA
Ulta Beauty
663.85
250.52
60.61%
ETSY
Etsy
61.58
8.86
16.81%
CHWY
Chewy
32.07
-5.20
-13.95%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 08, 2026